openPR Logo
Press release

Theophylline And Aminophylline Market with Current Trends Analysis,2016-2026

06-21-2016 10:10 AM CET | Health & Medicine

Press release from: Future Market Insights

Theophylline And Aminophylline Market with Current Trends

Xanthine is a nitrogenous compound found naturally in muscle tissue, liver spleen, pancreas and other organs as well as in the urine and is formed during the degradation of adenosine monophosphate to uric acid. Methylxanthines are methylated derivatives of the xanthine family which are derived either naturally or synthetically, which includes agents such as caffeine, theophylline, aminophylline and theobromine. Aminophylline is a soluble compound of theophylline with ethylenediamine in 2:1 ratio. Theophylline and aminophylline are caffeine like drugs also called as bronchodilators and are mainly used for the treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). They are muscle relaxants and helps improve contraction of the diaphragm and decreases the response of the airways to irritants, along with some anti-inflammatory actions. Although mechanism of action of methylxanthines are not completely known, the Global INITIATIVE for Chronic Obstructive Lung Disease, 2012 demonstrates that they may act as nonselective phosphodiesterase inhibitor. Theophylline and aminophylline are administered either intravenously or oral. Factors such as growing incidenceof respiratory disorders across the globe and demand for cost-effective treatment options are believed to play crucial role for the growth of global theophylline and aminophylline market. Rapid innovation in the field of personalized medicine presents a huge opportunity to manufacturers of theophylline and aminophylline market. However, launch of newer agents and severe side effects associated with the therapies may restrict the market penetration of the aminophylline and theophylline drugs. The global market for theophylline and aminophylline market is segmented on basis of disease indication, end user and geography:

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1543

Segmentation by Disease Indication

Chronic Obstructive Pulmonary Disease (COPD)

Asthma

Infant Apnea

Segmentation by End User

Hospitals

Clinics

Ambulatory surgical centers

If beta agonist are available aminophylline and theophylline drugs are not used as a primary treatment regime for the treatment of COPD due to their lower potency and higher potential for causing serious side effects, such as seizures and abnormal heart rhythms. However these medication can be prescribed in combination with other drugs by a doctor in case of severe COPD. Rising prevalence of respiratory disorders across globe and higher affordability of the methylxanthines are expected to create revenue traction over the forthcoming years. Based on disease indications, theophylline and aminophylline market is segmented as chronic obstructive pulmonary disease, asthma and infant apnea. Chronic obstructive pulmonary disease (COPD) disease indication segment is foreseen to lead the market. In addition, adoption of new technologies coupled with availability of high number of generic drugs for the treatment of asthma and COPD also stimulates the growth of theophylline and aminophylline market.

On the basis of end user, the global aminophylline and theophylline market has been segmented into hospitals, clinics, and ambulatory surgical centers. Hospital end user segment is anticipated to contribute the maximum share among end users.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1543

On the basis of geography theophylline and aminophylline market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America will continue to dominate the global theophylline and aminophylline market attributed to rising prevalence of lung diseases coupled with introduction of newer drugs. According to Centre for Disease Control and Prevention, chronic obstructive pulmonary disease (COPD) and acute lung injury are third leading cause of death in the U.S. In addition, according to American Lung Association, in 2010, approximately 134,676 deaths were reported due to COPD. Europe stands on the second position as a market leader in the global theophylline and aminophylline market attributed to rising prevalence of respiratory diseases. However, introduction of new generic drugs with greater efficacy exhibiting lesser side effects may restrict the market growth in the near future.

Theophylline And Aminophylline Market: Key players

Some of the major players in global theophylline and aminophylline market include GlaxoSmithKline plc, Altor BioScience Corporation, Ono Pharmaceutical Corporation Ltd., and Octapharma AG.

Browse Full Report@ http://www.futuremarketinsights.com/reports/theophylline-and-aminophylline-market

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Theophylline And Aminophylline Market with Current Trends Analysis,2016-2026 here

News-ID: 345222 • Views:

More Releases from Future Market Insights

Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Million by 2032
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolstered by a Robust 7.1% CAGR from 2022
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of the Metal Cans Industry, Catering to Health-conscious and Environmentally-aware Consumers
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033. The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 with a 4.8% CAGR
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute

All 5 Releases


More Releases for COPD

Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's. It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be
COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858 The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the
04-10-2017 | Health & Medicine
TMR
Asthma and COPD Drugs Market: High Costs of Asthma and COPD Drugs and Consumer A …
Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is a disease of the lungs characterized by obstruction to airflow that interferes with normal breathing. According to the WHO, COPD accounted for over 3 million deaths in 2012, which is equal to 6% of all deaths globally in that year. Moreover, the